@healthxchange
Pretty scathing review of diabetes apps by the Peterson institute
Essentially the cost benefit isn’t there for many patients even though many companies have been built in the diabetes mgmt space
https://www.forbes.com/sites/brucejapsen/2024/03/21/report-questions-value-of-diabetes-monitoring-apps/amp/